2,366 research outputs found

    On the Effects of Subvirial Initial Conditions and the Birth Temperature of R136

    Full text link
    We investigate the effect of different initial virial temperatures, Q, on the dynamics of star clusters. We find that the virial temperature has a strong effect on many aspects of the resulting system, including among others: the fraction of bodies escaping from the system, the depth of the collapse of the system, and the strength of the mass segregation. These differences deem the practice of using "cold" initial conditions no longer a simple choice of convenience. The choice of initial virial temperature must be carefully considered as its impact on the remainder of the simulation can be profound. We discuss the pitfalls and aim to describe the general behavior of the collapse and the resultant system as a function of the virial temperature so that a well reasoned choice of initial virial temperature can be made. We make a correction to the previous theoretical estimate for the minimum radius, RminR_{min}, of the cluster at the deepest moment of collapse to include a Q dependency, Rmin≈Q+N(−1/3)R_{min}\approx Q + N^{(-1/3)}, where NN is the number of particles. We use our numerical results to infer more about the initial conditions of the young cluster R136. Based on our analysis, we find that R136 was likely formed with a rather cool, but not cold, initial virial temperature (Q≈0.13Q\approx 0.13). Using the same analysis method, we examined 15 other young clusters and found the most common initial virial temperature to be between 0.18 and 0.25.Comment: Accepted for publication in MNRA

    S11/5 The role of the conserved tryptophan272 of the Paracoccus denitrificans cytochrome c oxidase in proton pumping

    Get PDF
    https://nsuworks.nova.edu/nsudigital_harrison/3448/thumbnail.jp

    The cytochrome ba3 oxidase from Thermus thermophilus does not generate a tryptophan radical during turnover: Implications for the mechanism of proton pumping

    Get PDF
    AbstractOxygen reduction by cytochrome ba3 oxidase from Thermus thermophilus was studied by stopped-flow and microsecond freeze-hyperquenching analyzed with UV-Vis and EPR spectroscopy. In the initial phase, the low-spin heme b560 is rapidly and almost completely oxidized (kobs>33,000s−1) whereas CuA remains nearly fully reduced. The internal equilibrium between CuA and heme b560 with forward and reverse rate constants of 4621s−1 and 3466s−1, respectively, indicates a ~7.5mV lower midpoint potential for CuA compared to heme b560. The formation of the oxidized enzyme is relatively slow (693s−1). In contrast to the Paracoccus denitrificans cytochrome aa3 oxidase, where in the last phase of the oxidative half cycle a radical from the strictly conserved Trp272 is formed, no radical is formed in the cytochrome ba3 oxidase. Mutation of the Trp229, the cytochrome ba3 oxidase homologue to the Trp272, did not abolish the activity, again in contrast to the Paracoccus cytochrome aa3 oxidase. Differences in the proton pumping mechanisms of Type A and Type B oxidases are discussed in view of the proposed role of the strictly conserved tryptophan residue in the mechanism of redox-linked proton pumping in Type A oxidases. In spite of the differences between the Type A and Type B oxidases, we conclude that protonation of the proton-loading site constitutes the major rate-limiting step in both catalytic cycles

    Recent Results of Solid-State Spectroscopy

    Full text link
    Solid state spectroscopy continues to be an important source of information on the mineralogical composition and physical properties of dust grains both in space and on planetary surfaces. With only a few exceptions, artificially produced or natural terrestrial analog materials, rather than 'real' cosmic dust grains, are the subject of solid state astrophysics. The Jena laboratory has provided a large number of data sets characterizing the UV, optical and infrared properties of such cosmic dust analogs. The present paper highlights recent developments and results achieved in this context, focussing on 'non-standard conditions' such as very low temperatures, very high temperatures and very long wavelengths.Comment: 15 pages, 10 figures. Contribution to an IAU Conference "The Molecular Universe" held in Toledo in June 201

    Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies:reviewing the available evidence

    Get PDF
    There has been a large increase in the incidence of invasive fungal infections (IFIs) over the past decades, largely because of the increasing size of the population at risk. One of the major risk groups for IFIs are patients with haematological malignancies treated with cytotoxic chemotherapy or undergoing haematopoietic stem cell transplantation. These IFIs are associated with high morbidity and mortality rates. Consequently, as the diagnosis of IFIs is difficult, antifungal prophylaxis is desirable in high-risk patients. Furthermore, as the economic impact of IFIs is also significant, it is important to assess the cost benefit and cost effectiveness of each prophylactic agent in order to aid decisions concerning which prophylactic agent provides the best value for limited healthcare resources. This article systematically reviews the available pharmacoeconomic evidence regarding antifungal prophylaxis in immunocompromised patients treated for haematological malignancies. Furthermore, specific points of interest concerning economic analyses of antifungal prophylaxis are briefly discussed. Considering the available evidence, antifungal prophylaxis in immunocompromised patients treated for haematological malignancies seems to be an intervention with favourable cost-benefit, cost-effectiveness and cost-saving potential. Furthermore, recently introduced antifungal agents seem to be attractive alternatives to fluconazole from a pharmacoeconomic point of view. However, due to wide heterogeneity in patient characteristics, underlying diseases, hospital settings and study methods in the included economic studies, as well as the lack of 'head-to-head' trials, it is difficult to find clear evidence of the economic advantages of a single prophylactic agent. Furthermore, we show that the results of cost-effectiveness analyses are highly dependent on several crucial factors that influence the baseline IFI incidence rates and, therefore, differ per patient population or region
    • …
    corecore